<p>Number of genome-wide significant SNPs (p-value <1.25E-7) with improved statistical significance (smaller p-value) from GWAS of Alzheimer disease, fibrinogen, HDL and uric acid using incorporated genotype data (new GWAS).</p
Background: Alzheimer’s disease is a common debilitating dementia with known heritability, for which...
Alzheimer’s disease (AD) is the most frequent neurodegenerative disease with an increasing prevalenc...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
<p>Results of top SNPs (p-value <1.25E-7) from GWAS of Alzheimer disease, fibrinogen, HDL and uric a...
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clini...
Objective To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset ...
Objective: Genome‐wide association studies (GWAS) have identified over 30 susceptibility loci assoc...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with an increasing prevalenc...
Genome Wide Association Studies (GWAS) of Alzheimer's disease with quantitative phenotype is an acti...
Recent meta-analyses combining direct genome-wide association studies (GWAS) with those of family hi...
Known genetic loci account for only a fraction of the genetic contribution to Alzheimer’s disease. H...
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous stu...
†<p>Position in base pairs, based on NCBI build 36.1 (hg18).</p>*<p>MAF is computed in genotyped and...
Background: Alzheimer’s disease is a common debilitating dementia with known heritability, for which...
Alzheimer’s disease (AD) is the most frequent neurodegenerative disease with an increasing prevalenc...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
<p>Results of top SNPs (p-value <1.25E-7) from GWAS of Alzheimer disease, fibrinogen, HDL and uric a...
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clini...
Objective To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset ...
Objective: Genome‐wide association studies (GWAS) have identified over 30 susceptibility loci assoc...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with an increasing prevalenc...
Genome Wide Association Studies (GWAS) of Alzheimer's disease with quantitative phenotype is an acti...
Recent meta-analyses combining direct genome-wide association studies (GWAS) with those of family hi...
Known genetic loci account for only a fraction of the genetic contribution to Alzheimer’s disease. H...
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous stu...
†<p>Position in base pairs, based on NCBI build 36.1 (hg18).</p>*<p>MAF is computed in genotyped and...
Background: Alzheimer’s disease is a common debilitating dementia with known heritability, for which...
Alzheimer’s disease (AD) is the most frequent neurodegenerative disease with an increasing prevalenc...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...